News

Net profit of GPT Healthcare rose 65.76% to Rs 12.73 crore in the quarter ended June 2026 as against Rs 7.68 crore during the previous quarter ended June 2025. Sales rose 17.82% to Rs 126.20 crore in the quarter ended June 2026 as against Rs 107.11 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales126.20107.11 18 OPM %19.1516.21 - PBDT24.0417.29 39 PBT17.1611.11 54 NP12.737.68 66 Powered by Capital Market - Live News

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 3 August 2026.

GPT Healthcare announced that the 37th Annual General Meeting(AGM) of the company will be held on 6 August 2026.

Net profit of GPT Healthcare rose 13.03% to Rs 14.57 crore in the quarter ended March 2026 as against Rs 12.89 crore during the previous quarter ended March 2025. Sales rose 24.63% to Rs 126.37 crore in the quarter ended March 2026 as against Rs 101.40 crore during the previous quarter ended March 2025.For the full year,net profit declined 15.42% to Rs 42.22 crore in the year ended March 2026 as against Rs 49.92 crore during the previous year ended March 2025. Sales rose 16.08% to Rs 472.55 crore in the year ended March 2026 as against Rs 407.09 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales126.37101.40 25 472.55407.09 16 OPM %18.4920.41 -17.8220.48 - PBDT22.8221.25 7 81.9088.38 -7 PBT15.8716.37 -3 54.8169.35 -21 NP14.5712.89 13 42.2249.92 -15 Powered by Capital Market - Live News

GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 18 May 2026, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.